2022 Journal Article The importance of training, accreditation, and guidelines for the practice of theranostics: the Australian perspectiveLee, Sze Ting, Emmett, Louise M., Pattison, David A., Hofman, Michael S., Bailey, Dale L., Latter, Melissa J., Francis, Roslyn J. and Scott, Andrew M. (2022). The importance of training, accreditation, and guidelines for the practice of theranostics: the Australian perspective. Journal of Nuclear Medicine, 63 (6), 819-822. doi: 10.2967/jnumed.122.263996 |
2022 Conference Publication TheraP: <sup>177</sup>Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603)Hofman, Michael S., Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Zhang, Alison Yan, McJannett, Margaret Mary, Stockler, Martin R., Williams, Scott, Martin, Andrew James and Davis, Ian D. (2022). TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Virtual, 3-7 June 2022. Philadelphia, PA USA: Lippincott Williams & Wilkins. |
2022 Conference Publication A prospective, multi-centre trial of FET-PET In Glioblastoma patients - the TROG 18.06 FIG Study: results of the Nuclear Medicine and Radiation Oncology credentialing programKoh, E. S., Moore, A., Francis, R. J., Ebert, M. A., Gan, H. K., Lee, S. T., Lau, E., Rossi, A., Grose, A., Ng, S. P., Barnes, E. H., Moffat, B. A., Scott, F. E., Adda, L., Foroudi, F., Nowak, A. K., Bailey, D. L., Back, M., Lourenco, R. De Abreu and Scott, A. M. (2022). A prospective, multi-centre trial of FET-PET In Glioblastoma patients - the TROG 18.06 FIG Study: results of the Nuclear Medicine and Radiation Oncology credentialing program. HOBOKEN: WILEY. |
2022 Journal Article Subcutaneous sarcoidosis (Darier–Roussy sarcoidosis) with extensive disease on positron emission tomography: a case report and review of the literatureYoun, Paul, Francis, Roslyn J., Preston, Henry and Lake, Fiona (2022). Subcutaneous sarcoidosis (Darier–Roussy sarcoidosis) with extensive disease on positron emission tomography: a case report and review of the literature. Respirology Case Reports, 10 (5) e0949. doi: 10.1002/rcr2.949 |
2022 Journal Article Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study)Lam, Virginie, Clarnette, Roger, Francis, Roslyn, Bynevelt, Michael, Watts, Gerald, Flicker, Leon, Orr, Carolyn F, Loh, Poh, Lautenschlager, Nicola, Reid, Christopher M., Foster, Jonathan K., Dhaliwal, Satvinder S., Robinson, Suzanne, Corti, Emily, Vaccarezza, Mauro, Horgan, Ben, Takechi, Ryusuke and Mamo, John (2022). Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study). BMJ Open, 12 (2) e058826, e058826. doi: 10.1136/bmjopen-2021-058826 |
2022 Conference Publication PSMA PET and FDG PET as predictors of response and prognosis in a randomized phase 2 trial of <SUP>177</SUP>Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic, castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603)Buteau, James Patrick, Martin, Andrew James, Emmett, Louise, Iravani, Amir, Sandhu, Shahneen Kaur, Joshua, Anthony M., Zhang, Alison Yan, Francis, Roslyn J., Scott, Andrew Mark, Azad, Arun, McJannett, Margaret Mary, Stockler, Martin R., Williams, Scott, Davis, Ian D. and Hofman, Michael S. (2022). PSMA PET and FDG PET as predictors of response and prognosis in a randomized phase 2 trial of 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic, castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.010 |
2022 Conference Publication ENZA-p: A randomized phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)Emmett, Louise, Subramaniam, Shalini, Martin, Andrew James, Zhang, Alison Yan, Yip, Sonia, Crumbaker, Megan, Rana, Nisha, Francis, Roslyn J., Hofman, Michael S., Joshua, Anthony M., Sandhu, Shahneen Kaur, Azad, Arun, Gedye, Craig, Weickhardt, Andrew James, Goh, Jeffrey C., Ng, Siobhan, Voskoboynik, Mark, McJannett, Margaret Mary, Stockler, Martin R. and Davis, Ian D. (2022). ENZA-p: A randomized phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.TPS205 |
2022 Journal Article Imaging in pleural mesothelioma: a review of the 15th International Conference of the International Mesothelioma Interest GroupArmato, Samuel G., Nowak, Anna K., Francis, Roslyn J., Katz, Sharyn I., Kholmatov, Manizha, Blyth, Kevin G., Gudmundsson, Eyjolfur, Kidd, Andrew C. and Gill, Ritu R. (2022). Imaging in pleural mesothelioma: a review of the 15th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 164, 76-83. doi: 10.1016/j.lungcan.2021.12.008 |
2022 Journal Article The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trialBellinge, Jamie W., Francis, Roslyn J., Lee, Sing C., Bondonno, Nicola P., Sim, Marc, Lewis, Joshua R., Watts, Gerald F. and Schultz, Carl J. (2022). The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial. The American Journal of Clinical Nutrition, 115 (1), 45-52. doi: 10.1093/ajcn/nqab306 |
2021 Journal Article 18F-sodium fluoride positron emission tomography activity predicts the development of new coronary artery calcificationsBellinge, Jamie W., Francis, Roslyn J., Lee, Sing Ching, Phillips, Michael, Rajwani, Adil, Lewis, Joshua R., Watts, Gerald F. and Schultz, Carl J. (2021). 18F-sodium fluoride positron emission tomography activity predicts the development of new coronary artery calcifications. Arteriosclerosis, Thrombosis, and Vascular Biology, 41 (1), 534-541. doi: 10.1161/ATVBAHA.120.315364 |
2021 Journal Article ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)Emmett, Louise, Subramaniam, Shalini, Joshua, Anthony M., Crumbaker, Megan, Martin, Andrew, Zhang, Alison Y., Rana, Nisha, Langford, Ailsa, Mitchell, Jenna, Yip, Sonia, Francis, Roslyn, Hofman, Michael S., Sandhu, Shahneen, Azad, Arun, Gedye, Craig, McJannett, Margaret, Stockler, Martin R. and Davis, Ian D. (2021). ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901). BJU International, 128 (5), 642-651. doi: 10.1111/bju.15491 |
2021 Journal Article Radiomics for identification and prediction in metastatic prostate cancer: a review of studiesKendrick, Jake, Francis, Roslyn, Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Jeraj, Robert, Kasisi, Collin, Rusanov, Branimir and Ebert, Martin (2021). Radiomics for identification and prediction in metastatic prostate cancer: a review of studies. Frontiers in Oncology, 11 (771787) 771787, 1-22. doi: 10.3389/fonc.2021.771787 |
2021 Journal Article Imaging inflammation in patients and animals: focus on PET imaging the vulnerable plaqueBartlett, Benjamin, Ludewick, Herbert P., Lee, Silvia, Verma, Shipra, Francis, Roslyn J. and Dwivedi, Girish (2021). Imaging inflammation in patients and animals: focus on PET imaging the vulnerable plaque. Cells, 10 (10) 2573, 2573. doi: 10.3390/cells10102573 |
2021 Journal Article Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotypeLam, Virginie, Takechi, Ryusuke, Hackett, Mark J., Francis, Roslyn, Bynevelt, Michael, Celliers, Liesl M., Nesbit, Michael, Mamsa, Somayra, Arfuso, Frank, Das, Sukanya, Koentgen, Frank, Hagan, Maree, Codd, Lincoln, Richardson, Kirsty, O’Mara, Brenton, Scharli, Rainer K., Morandeau, Laurence, Gauntlett, Jonathan, Leatherday, Christopher, Boucek, Jan and Mamo, John C.L. (2021). Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotype. PLoS Biology, 19 (9) e3001358, 1-26. doi: 10.1371/journal.pbio.3001358 |
2021 Journal Article Impact of COVID-19 pandemic on cardiovascular testing in Asia: the IAEA INCAPS-COVID StudyKudo, Takashi, Lahey, Ryan, Hirschfeld, Cole B., Williams, Michelle C., Lu, Bin, Alasnag, Mirvat, Bhatia, Mona, Henry Bom, Hee-Seung, Dautov, Tairkhan, Fazel, Reza, Karthikeyan, Ganesan, Keng, Felix Y.J., Rubinshtein, Ronen, Better, Nathan, Cerci, Rodrigo Julio, Dorbala, Sharmila, Raggi, Paolo, Shaw, Leslee J., Villines, Todd C., Vitola, João V., Choi, Andrew D., Malkovskiy, Eli, Goebel, Benjamin, Cohen, Yosef A., Randazzo, Michael, Pascual, Thomas N.B., Pynda, Yaroslav, Dondi, Maurizio, Paez, Diana ... Nguyen, Xuan Canh (2021). Impact of COVID-19 pandemic on cardiovascular testing in Asia: the IAEA INCAPS-COVID Study. JACC: Asia, 1 (2), 187-199. doi: 10.1016/j.jacasi.2021.06.002 |
2021 Journal Article Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessmentBarry, Nathaniel, Rowshanfarzad, Pejman, Francis, Roslyn J., Nowak, Anna K. and Ebert, Martin A. (2021). Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessment. Physical and Engineering Sciences in Medicine, 44 (4), 1131-1140. doi: 10.1007/s13246-021-01049-4 |
2021 Journal Article The australasian radiopharmaceutical trials network: Clinical trials, evidence, and opportunityFrancis, Roslyn J., Bailey, Dale L., Hofman, Michael S. and Scott, Andrew M. (2021). The australasian radiopharmaceutical trials network: Clinical trials, evidence, and opportunity. Journal of Nuclear Medicine, 62 (6), 755-756. doi: 10.2967/jnumed.120.258152 |
2021 Journal Article Repeatability of quantitative 18F-FET PET in glioblastomaFerjančič, Peter, Ebert, Martin A., Francis, Roslyn, Nowak, Anna K. and Jeraj, Robert (2021). Repeatability of quantitative 18F-FET PET in glioblastoma. Biomedical Physics and Engineering Express, 7 (3) 035020, 1-10. doi: 10.1088/2057-1976/abfae9 |
2021 Journal Article UpFrontPSMA: a randomized phase 2 study of sequential 177Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naive prostate cancer (clinical trial protocol)Dhiantravan, Nattakorn, Emmett, Louise, Joshua, Anthony M., Pattison, David A., Francis, Roslyn J., Williams, Scott, Sandhu, Shahneen, Davis, Ian D., Vela, Ian, Neha, Nitika, Bressel, Mathias, Murphy, Declan G., Hofman, Michael S. and Azad, Arun A. (2021). UpFrontPSMA: a randomized phase 2 study of sequential 177Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naive prostate cancer (clinical trial protocol). BJU International, 128 (3) bju.15384, 331-342. doi: 10.1111/bju.15384 |
2021 Journal Article Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trialde Feria Cardet, Rafael E., Hofman, Michael S., Segard, Tatiana, Yim, Jackie, Williams, Scott, Francis, Roslyn J., Frydenberg, Mark, Lawrentschuk, Nathan, Murphy, Declan G. and De Abreu Lourenco, Richard (2021). Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial. European Urology, 79 (3), 413-418. doi: 10.1016/j.eururo.2020.11.043 |